Foxo Technologies INC 8-K filings
OID
FOXO Technologies has announced that recent transactions, including debt-to-equity conversions, have resulted in stockholders' equity exceeding $4 million, allowing the company to regain compliance with NYSE American listing requirements.
OID
FOXO Technologies has completed a series of transactions, including a debt-for-equity swap, to improve its balance sheet and meet NYSE American listing requirements, while also appointing Seamus Lagan as the new CEO.
OID
Rennova Community Health, Inc. has issued a $1 million senior secured note, restructured $21 million of debt into equity, and appointed a new CEO, among other significant changes.
OID
FOXO Technologies Inc. has filed amendments to its Certificate of Incorporation to authorize the issuance of Series B and Series C Preferred Stock, establishing their rights, preferences, and limitations.
OID
FOXO Technologies Inc. announced the successful outcome of its Special Meeting of Shareholders, with all proposed resolutions receiving the necessary approvals.
OID
FOXO Technologies Inc. shareholders approved a reverse stock split and the issuance of shares related to several agreements at a special meeting on November 29, 2024.
OID
FOXO Technologies Inc. finalizes the acquisition of Rennova Community Health, Inc. (RCHI), amending the initial stock exchange agreement to include a $22 million senior note and $100 cash payment.
OID
8-K: FOXO Technologies Sets Date for Special Shareholder Meeting Amidst NYSE American Compliance Concerns
FOXO Technologies has announced a special shareholder meeting to be held on November 29, 2024, to address key proposals and ongoing compliance with NYSE American listing standards.
OID
FOXO Technologies has scheduled a special shareholder meeting on November 29, 2024, to vote on proposals including a potential reverse stock split, debt-to-equity conversions, and an equity line of credit.
OID
FOXO Technologies Inc. has amended its bylaws to reduce the quorum requirement for shareholder meetings from a majority to one-third of voting power.
OID
FOXO Technologies has authorized a new series of preferred stock and is taking steps to resolve outstanding legal issues, including a significant debt settlement.
OID
FOXO Technologies has received approval to convert $3.458 million in defaulted senior promissory notes into preferred stock, aiming to improve shareholder equity and meet NYSE listing requirements.
OID
FOXO Technologies reports on its 2024 progress, including two acquisitions expected to generate over $20 million in revenue in 2025, and plans for further growth and innovation.
OID
Rennova Community Health, Inc. has issued a $22 million senior secured note to Rennova Health, Inc., secured by all company assets.
OID
FOXO Technologies Inc. has acquired Myrtle Recovery Centers from Rennova Health in exchange for shares and a note, marking a significant move in the behavioral health sector.
OID
8-K: FOXO Technologies Increases Equity Purchase Agreement to $5 Million, Terminates Second Agreement
FOXO Technologies has increased its equity purchase agreement with ClearThink Capital Partners to $5 million and terminated a second agreement with the same firm.
OID
FOXO Technologies has successfully regained compliance with NYSE American listing standards after addressing outstanding listing fee payments.
OID
FOXO Technologies has entered into multiple agreements including advisory roles, private placement services, and a new executive services agreement.
OID
FOXO Technologies finalized the acquisition of Myrtle Recovery Centers for $500,000, paid primarily in stock, and issued additional shares for a senior note.
OID
8-K: FOXO Technologies Inc. Faces NYSE Non-Compliance Notice Due to Stockholders' Deficit and Losses
FOXO Technologies Inc. has received a notice from the NYSE American stating the company is not in compliance with listing standards due to a stockholders' deficit of $14.9 million and recent losses.
OID
FOXO Technologies is at risk of being delisted from the NYSE American due to unpaid fees, despite initially believing they had resolved the issue.
OID
FOXO Technologies Inc. has obtained up to $2.8 million in senior notes to fund the acquisition of Myrtle Recovery Centers, Inc. and for general working capital.
OID
FOXO Technologies received a notice of noncompliance from the NYSE American due to unpaid listing fees, but has since made the required payments and is working to regain compliance.
OID
FOXO Technologies Inc. has received a notice of non-compliance from the NYSE American due to overdue listing fees, putting its continued listing status at risk.
OID
FOXO Technologies is set to acquire Myrtle Recovery Centers and Rennova Community Health, including Big South Fork Medical Center, from Rennova Health in a share exchange agreement valued at approximately $20.5 million.
OID
FOXO Technologies Inc. announced it will restate its financial statements for the three and nine months ended September 30, 2023, due to errors in accounting for common stock warrants.
OID
FOXO Technologies Inc. has entered into an agreement with Smithline Family Trust II to exchange warrants for shares of Class A Common Stock, subject to certain limitations.
OID
FOXO Technologies issued shares for services, and secured a convertible note, increasing its outstanding share count.
OID
FOXO Technologies has received a notice from the NYSE American for failing to file its annual report, placing its listing status at risk.
OID
FOXO Technologies has entered a non-binding agreement for a potential merger with M2i Global, a company focused on developing critical mineral supply chains.